Linda Llewelyn files to sell 8,519 restricted shares (HCAT)

Rhea-AI Filing Summary

Health Catalyst, Inc. proposed the sale of 8,519 shares of Restricted Stock on 06/01/2026 under a Form 144 notice. The filing shows these shares are linked to compensation. The filing also reports 13,836 shares sold on 03/02/2026 by Linda Llewelyn, with proceeds noted as $22,966.38.

Insights

Insider Transactions Analyst

Proposed sale of 8,519 restricted shares by an insider; prior sale of 13,836 shares was reported.

The notice lists 8,519 shares of Restricted Stock proposed for sale on 06/01/2026, described as tied to compensation. The filer also reported a prior disposition of 13,836 shares on 03/02/2026 with proceeds shown as $22,966.38.

These are administrative disclosures of an insider sale plan; cash-flow treatment and any trading method are not provided in the excerpt. Subsequent filings would show completion or settlement details.

Key Figures

Proposed shares to be sold: 8,519 shares Shares sold in past 3 months: 13,836 shares Proceeds reported: $22,966.38

3 metrics

Proposed shares to be sold 8,519 shares Securities to be sold on 06/01/2026

Shares sold in past 3 months 13,836 shares Disposition dated 03/02/2026

Proceeds reported $22,966.38 Amount associated with prior 03/02/2026 disposition

Key Terms

Restricted Stock, Form 144, Compensation

3 terms

Restricted Stock financial

"Securities To Be Sold ... Restricted Stock ... Compensation"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Compensation financial

"Securities To Be Sold ... Compensation"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 06/01/2026 - 05:36 PM Accepted by SEC EDGAR 06/01/2026 - 05:36 PM Learn about SEC filing dates

FAQ

What does Health Catalyst's (HCAT) Form 144 disclose?

The Form 144 discloses a proposed sale of 8,519 restricted shares on 06/01/2026. It also reports a prior disposition of 13,836 shares on 03/02/2026, tied to compensation, with proceeds listed as $22,966.38.

Who is the filer on the HCAT Form 144 and what security is affected?

The filing lists Linda Llewelyn as the reporting person and identifies Restricted Stock of Health Catalyst, Inc. The notice reports shares related to compensation and specifies the proposed sale date as 06/01/2026 in the excerpt.

How many shares were sold in the prior transaction reported in the Form 144?

The excerpt shows a prior sale of 13,836 shares on 03/02/2026. The filing ties that prior disposition to restricted stock activity and includes proceeds recorded as $22,966.38 in the provided lines.

Does the Form 144 indicate how proceeds will be used or who receives them?

The excerpt does not specify use of proceeds or the recipient beyond the reporting person. It lists proceeds of $22,966.38 for the prior sale, but the filing does not describe cash-flow treatment or disposition method in the provided content.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	8519	11672.73	73894020	06/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/01/2026	Restricted Stock	Health Catalyst, Inc.			8519	06/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Linda Llewelyn c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	03/02/2026	13836	22966.38

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)